Comparison of imaging biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging

Archives of Neurology

Volumn 69, Issue 5, 2012, Pages 614-622

  Whitwell, Jennifer L ^a   Wiste, Heather J ^a   Weigand, Stephen D ^a   Rocca, Walter A ^a,b   Knopman, David S ^b   Roberts, Rosebud O ^a   Boeve, Bradley F ^b   Petersen, Ronald C ^b   Jack, Clifford R ^a  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGE; AGED; ALZHEIMER DISEASE; ALZHEIMER DISEASE NEUROIMAGING INITIATIVE; ARTICLE; BRAIN SIZE; CANADA; CLINICAL STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; EDUCATIONAL STATUS; FAMILY HISTORY; FEMALE; GENOTYPE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MAYO CLINIC STUDY OF AGING; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POPULATION RESEARCH; PRIORITY JOURNAL; SEX; UNITED STATES;

EID: 84860906672     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.3029     Document Type: Article

References (45)

1. Whitwell JL, Przybelski SA, Weigand SD, et al. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress frommild cognitive impairment to Alzheimer's disease. Brain. 2007;130(pt 7):1777-1786. (Pubitemid 47343806)
2. Whitwell JL, Shiung MM, Przybelski SA, et al. MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology. 2008;70(7):512-520. (Pubitemid 351653375)
3. Chételat G, Desgranges B, De La Sayette V, Viader F, Eustache F, Baron JC. Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. Neuroreport. 2002;13(15):1939-1943. (Pubitemid 35398965)
4. Jack CR Jr, Petersen RC, Xu YC, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 1999;52(7):1397- 1403. (Pubitemid 29190530)
5. Ferreira LK, Diniz BS, Forlenza OV, Busatto GF, Zanetti MV. Neurostructural predictors of Alzheimer's disease: a meta-analysis of VBM studies [published online December 11, 2009]. Neurobiol Aging. doi:10.1016/j.neurobiolaging.2009.11.008.
6. Jack CR Jr, Slomkowski M, Gracon S, et al. MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Neurology. 2003;60(2):253-260. (Pubitemid 36152018)
7. Schott JM, Frost C, Whitwell JL, et al. Combining short interval MRI in Alzheimer's disease: implications for therapeutic trials. J Neurol. 2006;253(9):1147-1153. (Pubitemid 44511470)
8. Mueller SG, Weiner MW, Thal LJ, et al. The Alzheimer's Disease Neuroimaging Initiative. Neuroimaging Clin N Am. 2005;15(4):869-877, xi-xii. (Pubitemid 43162384)
9. Jack CR Jr, Bernstein MA, Fox NC, et al. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging. 2008;27(4):685-691. (Pubitemid 351508080)
10. Jack CR Jr, Dickson DW, Parisi JE, et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology. 2002;58(5):750-757. (Pubitemid 34211554)
11. Fox NC, Warrington EK, Freeborough PA, et al. Presymptomatic hippocampal atrophy in Alzheimer's disease: a longitudinal MRI study. Brain. 1996;119(pt 6):2001-2007.
12. Roberts RO, Geda YE, Knopman DS, et al. The Mayo Clinic Study of Aging: design and sampling, participation, baselinemeasures and sample characteristics. Neuroepidemiology. 2008;30(1):58-69. (Pubitemid 351311727)
13. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996;71(3):266-274.
14. St Sauver JL, Grossardt BR, Yawn BP, Melton LJ III, Rocca WA. Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester Epidemiology Project. Am J Epidemiol. 2011;173(9):1059-1068.
15. Petersen RC, Roberts RO, Knopman DS, et al Mayo Clinic Study of Aging. Prevalence of mild cognitive impairment is higher in men. Neurology. 2010;75(10):889-897.
16. Harris ME, Ivnik RJ, Smith GE. Mayo's Older Americans Normative Studies: expanded AVLT Recognition Trial norms for ages 57 to 98. J Clin Exp Neuropsychol. 2002;24(2):214-220. (Pubitemid 34496870)
17. Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183-194. (Pubitemid 39222988)
18. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412-2414. (Pubitemid 23346995)
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. ed 4. Washington, DC: American Psychiatric Association; 1994.
20. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State:" a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
21. Briellmann RS, Syngeniotis A, Jackson GD. Comparison of hippocampal volumetry at 1.5 Tesla and at 3 Tesla. Epilepsia. 2001;42(8):1021-1024. (Pubitemid 32802067)
22. Jovicich J, Czanner S, Greve D, et al. Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage. 2006;30(2):436-443.
23. Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging. 1998;17(1):87-97. (Pubitemid 128742012)
24. Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33(3):341-355. (Pubitemid 34162530)
25. Morey RA, Petty CM, Xu Y, et al. A comparison of automated segmentation and manual tracing for quantifying hippocampal and amygdala volumes. Neuroimage. 2009;45(3):855-866.
26. Whitwell JL, Jack CR Jr, Boeve BF, et al. Imaging correlates of pathology in corticobasal syndrome. Neurology. 2010;75(21):1879-1887.
27. Acion L, Peterson JJ, Temple S, Arndt S. Probabilistic index: an intuitive nonparametric approach to measuring the size of treatment effects. Stat Med. 2006; 25(4):591-602. (Pubitemid 43174526)
28. den Heijer T, van der Lijn F, Koudstaal PJ, et al. A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline. Brain. 2010;133(pt 4):1163-1172.
29. Jagust WJ, Landau SM, Shaw LM, et al Alzheimer's Disease Neuroimaging Initiative. Relationships between biomarkers in aging and dementia. Neurology. 2009;73(15):1193-1199.
30. Jack CR Jr, Lowe VJ, Senjem ML, et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain. 2008;131(pt 3):665-680.
31. Schneider JA, Aggarwal NT, Barnes L, Boyle P, Bennett DA. The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis. 2009;18(3):691-701.
32. Jack CR Jr, Weigand SD, Shiung MM, et al. Atrophy rates accelerate in amnestic mild cognitive impairment. Neurology. 2008;70(19, pt 2):1740-1752. (Pubitemid 351653966)
33. Jellinger KA, Attems J. Prevalence of dementia disorders in the oldest-old: an autopsy study. Acta Neuropathol. 2010;119(4):421-433.
34. Jicha GA, Parisi JE, Dickson DW, et al. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. Arch Neurol. 2006;63(5):674-681.
35. Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol. 2009;66(2):200-208.
36. Barnhart RL, van Belle G, Edland SD, et al. Geographically overlapping Alzheimer's disease registries: comparisons and implications. J Geriatr Psychiatry Neurol. 1995;8(4):203-208.
37. Kokmen E, Ozsarfati Y, Beard CM, O'Brien PC, Rocca WA. Impact of referral bias on clinical and epidemiological studies of Alzheimer's disease. J Clin Epidemiol. 1996;49(1):79-83. (Pubitemid 26089553)
38. Knopman DS, Petersen RC, Rocca WA, Larson EB, Ganguli M. Passive casefinding for Alzheimer's disease and dementia in two U.S. communities. Alzheimers Dement. 2011;7(1):53-60.
39. Tsuang D, Kukull W, Sheppard L, et al. Impact of sample selection on APOE epsilon 4 allele frequency: a comparison of two Alzheimer's disease samples. J Am Geriatr Soc. 1996;44(6):704-707.
40. Mu Q, Xie J, Wen Z, Weng Y, Shuyun Z. A quantitative MR study of the hippocampal formation, the amygdala, and the temporal horn of the lateral ventricle in healthy subjects 40 to 90 years of age. AJNR Am J Neuroradiol. 1999;20(2):207-211. (Pubitemid 30418699)
41. Komlos J, Breitfelder A. Are Americans shorter (partly) because they are fatter? a comparison of US and Dutch children's height and BMI values. Ann Hum Biol. 2007;34(6):593-606. (Pubitemid 351412256)
42. Caracciolo B, Palmer K, Monastero R, Winblad B, Bäckman L, Fratiglioni L. Occurrence of cognitive impairment and dementia in the community: a 9-yearlong prospective study. Neurology. 2008;70(19, pt 2):1778-1785. (Pubitemid 351653963)
43. Luck T, Luppa M, Briel S, et al. Mild cognitive impairment: incidence and risk factors: results of the Leipzig Longitudinal Study of the Aged. J Am Geriatr Soc. 2010;58(10):1903-1910.
44. Roberts RO, Geda YE, Knopman DS, et al. The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging. Neurology. 2012;78(5):342-351.
45. Unverzagt FW, Ogunniyi A, Taler V, et al. Incidence and risk factors for cognitive impairment no dementia and mild cognitive impairment in African Americans. Alzheimer Dis Assoc Disord. 2011;25(1):4-10.